Author:
Jackson Don V,Pope Ellen K,McMahan Renee A,Robert Cooper M,Atkins James N,Callahan Richard D,Paschold Eugene H,Grimm Ruby A,Hopkins Judith O,Muss Hyman B,Richards Frederick,Stuart John J,White Douglas R,Zekan Patricia J,Cruz Julia M,Spurr Charles L,Capizzi Robert L
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Neurology,Neurology,Oncology
Reference13 articles.
1. Jackson DV, Bender RA: The clinical pharmacology of the vinca alkaloids, epipodophyllotoxins, and maytansine. In: Pinedo M (ed) Clinical pharmacology of anti-neoplastic drugs. Elsevier/North-Holland Biomedical Press, pp 277–294, 1978.
2. Carbone PP, Bono V, Frei E III, Brindley CO: Clinical studies with vincristine. Blood 21:640–647, 1963.
3. Holland JF, Scharlau C, Gailani et al: Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res 33:1258–1264, 1973.
4. Jackson DV, Sethi VS, Spurr CL et al: Intravenous vincristine infusion: phase I trial. Cancer 48:2559–2564, 1981.
5. Kaplan RS, Wiernik PH: Neurotoxicity of antineoplastic drugs. Sem Onc 9:103–130, 1982.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献